While moderate weight reduction is often therapeutically beneficialparticularly in improving metabolic disorders such as type 2 diabetes and obesitysubstantial or prolonged weight loss has been increasingly implicated in adverse skeletal outcomes
There are also theoretical concerns about growth hormone's proliferative effects, though evidence linking physiological GH elevation to cancer risk in adults remains inconclusive
Tirzepatide is a dual agonist that co-activates the GIP receptor (glucose-dependent insulinotropic polypeptide receptor) alongside GLP-1R
That single chemical addition converts a brief, pulsatile GHRH stimulus into week-long GH and IGF-1 elevation, with once-weekly dosing in human trials versus the multiple daily administrations the no-DAC core's minutes-scale half-life would demand
However, it is important to speak with a healthcare provider about the benefits and risks associated with taking this drug over a long period of time
Whether youre new to Semaglutide or looking to improve your current results, our team works with you to develop a plan that fits your lifestyle and your goals
